Tag: Xeltis
Xeltis secures additional €12.5 million from European Innovation Council
Xeltis has announced the closing of an additional €12.5 million in funding from the European Innovat...
Xeltis secures funding to progress clinical trials
Xeltis has raised €32 million in a Series D2 equity fundraise, backed by a syndicate of current and ...
Xeltis announces “promising outcomes” in restorative graft trials following EU financing
Xeltis has announced promising initial outcomes from two key vascular trials involving its restorati...
EACTS2016: World’s first heart valve that “enables cardiovascular restoration” successfully implanted in three children
Xeltis has announced that three pediatric patients have been successfully implanted with the wor...
Xeltis established international clinical advisory board
Xeltis AG, a clinical-stage medical device company developing the first-ever heart valves design...
